Akthelia Pharmaceuticals has filed a new UK patent application, marking an important milestone in the expansion of the company’s innovation pipeline.   The patent filing follows the signing of a licensing agreement in December with partners in the Horizon Europe IN-ARMOR project. The collaboration focuses on the discovery and optimisation of novel immune-modulating small molecules, together with Enamine, a Ukrainian contract research organization (CRO) specializing in medici

Icelandic biotech R&D company Akthelia Pharmaceuticals has appointed Brynjólfur Þór Gylfason as Financial Controller. Gylfason brings more than twenty years of financial leadership experience across the biotechnology and healthcare sectors, investment management, and advisory services. He joins Akthelia from GS Holdings Group. He has also held roles at Danforth Advisors, WuXi NextCODE, Virðing hf., and Deloitte. Gylfason holds a Cand. Oecon. degree in Auditing from the Univer

Icelandic biotech R&D company Akthelia Pharmaceuticals has appointed Stefán Jónsson, PhD, as Head of Chemistry, Manufacturing, and Control (CMC) and Intellectual Property. In this role, Dr. Jónsson will lead strategy and execution across development, analytical, and manufacturing processes, pharmaceutical substances and formulations, as well as the company’s intellectual property strategy. Dr. Jónsson brings two decades of experience in analytical methodologies, proteomics, m

Akthelia's CEO, Egill Masson at the International BIO Convention 2025

Tanya Zharov, attorney has joined the Board of Directors of Akthelia as an independent director. Tanya brings over 25 years of experience in biotechnology, finance, and corporate governance, with an extensive background across the pharmaceutical and life-science industries. She is current General Counsel and Deputy CEO of Icelandic biosimilar company Alvotech. prior to that she was Deputy CEO at deCODE Genetics. From 2008 to 2015, she was a Founding Partner and Deputy CEO of

Technical University Munich’s Prof. Dr. Markus Gerhard Joins Akthelia's Scientific Advisory Board.

Akthelia's CSO and collaborators have published a review paper on modulating innate immunity in the context of hematologic malignancies.

We’re proud to share that two Akthelia Pharmaceuticals employees Helga Kristín Einarsdóttir and Sonja Srdanovi ć are co-authors on a newly published scientific paper in Drug Discovery Today ! The article, titled “Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections,” explores how a class of compounds called HDAC inhibitors could help the body’s first line of defence — the innate immune system — fight infections more effectively.

Akthelia Pharmaceuticals is featured in today's edition of the leading Icelandic business newspaper Viðskiptablaðið.

Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS

Prof. dr. Nicole Blijlevens - a leading expert in gastrointestinal mucositis has joined Akthelia's Scientific Advisory Board.

Akthelia Pharma will present exciting new translational data, and partnering and capital raising objectives at Nordic Life Science Days 2024

Akthelia Pharmaceuticals announce its award of the European Commission Seal of Excellence, a quality recognition by the European Union.

Akthelia Pharmaceuticals is at a pivotal juncture, with a strongly validated and developable lead asset, ready to enter IND-enabling studies

Dr Sonja Srdanović joins Akthelia Pharma as R&D Program Manager for Inflammation and Infection

Akthelia Pharmaceuticals will attend the Nordic Life Science Days Summit in Copenhagen, 9 - 30 November 2023 REYKJAVIK, Iceland -- 30...

Helga Kristín Einarsdóttir joins Akthelia as R&D Program Manager for Wound Therapeutics.

Akthelia Pharmaceuticals and the University of Iceland Secure a €6M EU Horizon Grant to Combat Antimicrobial Resistance (AMR)

Akthelia Pharma selected to present at the Science4Peace Summit in Stockholm, Dec 2022

Akthelia Pharmaceuticals Participates in the LSX Leaders Nordic Congress 2022